Medication info
Neocandec Tablet 8 mg (Candesartan Cilexetil)

Neocandec Tablet 8 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
NOKSIBJA Co., Ltd.
Appearance
Pink, biconvex, round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201500208 · Approved 2015.01.15 · Insurance code 643605660

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time each day, with or without food. 1. Essential hypertension Adults: The recommended initial and maintenance dose is candesartan cilexetil 8 ∼ 16 mg orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is needed. Patients with intravascular volume depletion: Use an initial dose of 4 mg with careful monitoring in patients at increased risk of hypotension, such as those with volume depletion. Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure Adults: The recommended initial dose is 4 mg once daily. Double the dose at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is needed.
Child dose
Essential hypertension - Pediatrics: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. Heart failure - Pediatrics: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Ingredients

Manufacturer
NOKSIBJA Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is primarily used to control blood pressure in patients with essential hypertension. It is also effective in heart failure patients who have impaired left ventricular systolic function and a left ventricular ejection fraction of 40% or less. It is particularly suitable for patients who require additional treatment with ACE inhibitors or cannot tolerate them. Therefore, it helps stabilize blood pressure and improve heart function.

How to take

Adult dose

Take this medicine at the same time each day, with or without food. 1. Essential hypertension Adults: The recommended initial and maintenance dose is candesartan cilexetil 8 ∼ 16 mg orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Elderly patients: No adjustment of the initial dose is needed. Patients with intravascular volume depletion: Use an initial dose of 4 mg with careful monitoring in patients at increased risk of hypotension, such as those with volume depletion. Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure Adults: The recommended initial dose is 4 mg once daily. Double the dose at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is needed.

Child dose

Essential hypertension - Pediatrics: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. Heart failure - Pediatrics: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. Patients with an allergy to this medication, pregnant or nursing women, patients with severe liver dysfunction, and those with hereditary angioedema should not take this medication. Elderly patients or those with impaired kidney function, hyperkalemia, or heart valve disease should use this medication with caution, and regular blood tests to monitor kidney function and potassium levels are important. Side effects such as dizziness, back pain, respiratory infections, may occur during treatment, and in severe cases, hypotension, worsening kidney function, and hyperkalemia may occur, so any abnormal symptoms should be reported to a healthcare professional immediately. Blood pressure may drop too low or shock symptoms may appear, so especially for heart failure patients or those taking diuretics, the initial dosage should be started low and their condition closely monitored. The effect of this medication may increase when taken with other blood pressure-lowering medications, so when used in combination, it should be taken according to the instructions of a healthcare professional. Particularly, caution should be taken when used with potassium-sparing diuretics or potassium supplements, as it may increase blood potassium levels to dangerous levels. Women of childbearing potential should fully understand the risks of this medication and may need to take a pregnancy test. If planning to become pregnant, consult a physician. Nursing women are advised to avoid this medication, and if necessary, it is recommended to discontinue breastfeeding. This medication should not be used in children and adolescents since safety and efficacy have not been established. Dizziness or drowsiness may occur when driving or operating machinery, so caution is advised. In case of overdose, symptoms such as low blood pressure, dizziness, and rapid heart rate may occur, and immediate medical attention is necessary. This medication should be stored out of reach of children, and transferring it to another container may cause quality degradation or accidents, so caution is urged.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • weakness
  • fever
  • sensory abnormalities
  • dyspepsia
  • gastroenteritis
  • tachycardia
  • palpitations
Show 66 more
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • nasal bleeding
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal function impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzymes
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorder
  • decreased libido
  • amnesia
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Pink, biconvex, round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.